{"nct_id":"NCT04998604","title":"EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients","status":"COMPLETED","status_verified_date":"2025-09","start_date":"2021-09-27","start_date_type":"ACTUAL","primary_completion_date":"2024-10-16","primary_completion_date_type":"ACTUAL","completion_date":"2024-12-27","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["SNY"]}